Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Androgen excess in breast cancer development: implications for prevention and treatment.

Secreto G, Girombelli A, Krogh V.

Endocr Relat Cancer. 2018 Nov 1. pii: ERC-18-0429.R1. doi: 10.1530/ERC-18-0429. [Epub ahead of print] Review.

PMID:
30403656
2.

Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy.

Secreto G, Muti P, Sant M, Meneghini E, Krogh V.

Endocr Relat Cancer. 2017 Nov;24(11):C21-C29. doi: 10.1530/ERC-17-0251. Epub 2017 Aug 16.

PMID:
28814452
3.

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer.

Muti P, Secreto G, Krogh V.

Breast Cancer Res Treat. 2017 Jun;163(3):631-632. doi: 10.1007/s10549-017-4194-8. Epub 2017 Mar 18. No abstract available.

PMID:
28315966
4.

A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women.

Secreto G, Sieri S, Agnoli C, Grioni S, Muti P, Zumoff B, Sant M, Meneghini E, Krogh V.

Breast Cancer Res Treat. 2016 Aug;158(3):553-61. doi: 10.1007/s10549-016-3901-1. Epub 2016 Jul 9.

PMID:
27393623
5.

Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.

Secreto G, Venturelli E, Meneghini E, Carcangiu ML, Paolini B, Agresti R, Pellitteri C, Berrino F, Gion M, Cogliati P, Saragò G, Micheli A.

BMC Cancer. 2012 Dec 14;12:599. doi: 10.1186/1471-2407-12-599.

6.
7.

Influence of fatty acid-free diet on mammary tumor development and growth rate in HER-2/Neu transgenic mice.

Rossini A, Zanobbio L, Sfondrini L, Cavalleri A, Secreto G, Morelli D, Palazzo M, Sommariva M, Tagliabue E, Rumio C, Balsari A.

J Cell Physiol. 2013 Jan;228(1):242-9. doi: 10.1002/jcp.24130.

PMID:
22689438
8.

Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.

Secreto G, Meneghini E, Venturelli E, Cogliati P, Agresti R, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A, Micheli A.

Int J Biol Markers. 2011 Oct-Dec;26(4):241-6. doi: 10.5301/JBM.2011.8883.

PMID:
22180173
9.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

10.

Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.

Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Grioni S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P.

Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):729-37. doi: 10.1158/1055-9965.EPI-09-1229. Epub 2010 Mar 3.

11.

Testosterone and biological characteristics of breast cancers in postmenopausal women.

Secreto G, Venturelli E, Meneghini E, Greco M, Ferraris C, Gion M, Zancan M, Fabricio AS, Berrino F, Cavalleri A, Micheli A.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2942-8. doi: 10.1158/1055-9965.EPI-09-0540. Epub 2009 Oct 20.

12.

Bilateral breast cancer in a male patient with hepatocellular carcinoma. A case report.

Rubino A, Fissi S, Secreto G.

Ann Ital Chir. 2008 Mar-Apr;79(2):117-9.

PMID:
18727274
13.

Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.

Pasanisi P, Venturelli E, Morelli D, Fontana L, Secreto G, Berrino F.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1719-22. doi: 10.1158/1055-9965.EPI-07-0654.

14.

Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.

Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Sieri S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P.

J Natl Cancer Inst. 2008 Jun 18;100(12):898-905. doi: 10.1093/jnci/djn171. Epub 2008 Jun 10.

15.

Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.

Lissoni P, Brivio F, Fumagalli L, Messina G, Secreto G, Romelli B, Fumagalli G, Rovelli F, Colciago M, Brera G.

In Vivo. 2007 Jul-Aug;21(4):647-50.

16.

Plasma testosterone and prognosis of postmenopausal breast cancer patients.

Micheli A, Meneghini E, Secreto G, Berrino F, Venturelli E, Cavalleri A, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Veronesi U, Formelli F.

J Clin Oncol. 2007 Jul 1;25(19):2685-90. Epub 2007 Jun 4.

PMID:
17548841
17.

Re: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Micheli A, Secreto G, Meneghini E, Krogh V, Muti P, Venturelli E, Berrino F.

J Natl Cancer Inst. 2007 Mar 7;99(5):408-9; author reply 409-10. No abstract available.

PMID:
17341734
18.

Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer.

Barba M, Cavalleri A, Schünemann HJ, Krogh V, Evangelista A, Secreto G, Micheli A, Zhou Q, Fuhrman B, Teter B, Berrino F, Muti P.

Int J Biol Markers. 2006 Oct-Dec;21(4):242-5.

PMID:
17177163
19.

Plant-based diet, serum fatty acid profile, and free radicals in postmenopausal women: the diet and androgens (DIANA) randomized trial.

Colombo C, Muti P, Pala V, Cavalleri A, Venturelli E, Locardi M, Berrino F, Secreto G.

Int J Biol Markers. 2005 Jul-Sep;20(3):169-76.

PMID:
16240844
20.

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.

J Natl Cancer Inst. 2005 May 18;97(10):755-65.

PMID:
15900045
21.

Evaluation of reactive oxygen metabolites in frozen serum samples. Effect of storage and repeated thawing.

Cavalleri A, Colombo C, Venturelli E, Miceli R, Mariani L, Cornelli U, Pala V, Berrino F, Secreto G.

Int J Biol Markers. 2004 Jul-Sep;19(3):250-3.

PMID:
15503829
22.

Serum testosterone levels and breast cancer recurrence.

Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, Berselli E, Muti P, Secreto G.

Int J Cancer. 2005 Jan 20;113(3):499-502.

23.

Endogenous sex hormones and subsequent breast cancer in premenopausal women.

Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, Sieri S, Pala V, Berrino F.

Int J Cancer. 2004 Nov 1;112(2):312-8.

24.

Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study.

Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T, Marubini E.

Maturitas. 2004 Jan 20;47(1):11-20.

PMID:
14706761
25.

Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial.

Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, Pala V, Sieri S, Berrino F.

Eur J Clin Nutr. 2003 Sep;57(9):1079-88.

PMID:
12947426
26.

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.

Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C; Endogenous Hormones Breast Cancer Collaborative Group.

J Natl Cancer Inst. 2003 Aug 20;95(16):1218-26.

PMID:
12928347
27.

DIANA trials on diet and endogenous hormones.

Berrino F, Bellati C, Ooldani S, Mastroianni A, Allegro G, Berselli E, Venturelli E, Cavalleri A, Cambié M, Pala V, Pasanisi P, Secreto G.

IARC Sci Publ. 2002;156:439-44. No abstract available.

PMID:
12484231
28.

Quantitative analysis of urinary daidzein and equol by gas chromatography after solid-phase extraction and high-performance liquid chromatography.

Venturelli E, Rinaldi S, Cambiè M, Cavalleri A, Secreto G.

Int J Biol Markers. 2002 Jul-Sep;17(3):182-8.

PMID:
12408469
29.

Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: the Menfis randomized trial.

Chiechi LM, Secreto G, D'Amore M, Fanelli M, Venturelli E, Cantatore F, Valerio T, Laselva G, Loizzi P.

Maturitas. 2002 Aug 30;42(4):295-300.

PMID:
12191852
30.

The effects of a soy rich diet on serum lipids: the Menfis randomized trial.

Chiechi LM, Secreto G, Vimercati A, Greco P, Venturelli E, Pansini F, Fanelli M, Loizzi P, Selvaggi L.

Maturitas. 2002 Feb 26;41(2):97-104.

PMID:
11836040
31.

Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women.

Rinaldi S, Déchaud H, Biessy C, Morin-Raverot V, Toniolo P, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Secreto G, Ciampi A, Riboli E, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):757-65.

32.

Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial.

Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):25-33.

33.

Factors of risk for breast cancer influencing post-menopausal long-term hormone replacement therapy.

Chiechi LM, Secreto G.

Tumori. 2000 Jan-Feb;86(1):12-6. Review.

PMID:
10778760
34.
35.

Breast cancer and replacement therapy: which women are at risk?

Chiechi LM, Secreto G.

Clin Exp Obstet Gynecol. 1999;26(2):105-8.

PMID:
10459451
36.

Replacement therapy in postmenopausal women and breast cancer risk.

Chiechi LM, Secreto G.

Int J Gynaecol Obstet. 1999 Jan;64(1):79-80. No abstract available.

PMID:
10190679
37.

[Treatment of prostate adenoma with finasteride. Contribution of cases].

Avogadro A, Secreto G, Gattoni F, Spadone M, Sacrini A, Blanc M.

Minerva Urol Nefrol. 1996 Dec;48(4):199-201. Italian.

PMID:
9005588
38.

Intratumour amount of sex steroids in elderly breast cancer patients. An approach to the biological characterization of mammary tumours in the elderly.

Secreto G, Venturelli E, Bucci A, Piromalli D, Fariselli G, Galante E.

J Steroid Biochem Mol Biol. 1996 Aug;58(5-6):557-61.

PMID:
8918982
39.

Growth stimulatory effect and metabolism of testosterone in MCF-7 human breast cancer cells.

Venturelli E, Coradini D, Gornati D, Secreto G.

Int J Oncol. 1996 Apr;8(4):687-92.

PMID:
21544414
40.

Serum sex hormone levels after menopause and subsequent breast cancer.

Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G.

J Natl Cancer Inst. 1996 Mar 6;88(5):291-6.

PMID:
8614008
41.

Methods for urinary testosterone analysis.

Venturelli E, Cavalleri A, Secreto G.

J Chromatogr B Biomed Appl. 1995 Sep 15;671(1-2):363-80. Review.

PMID:
8520702
42.

Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues.

Recchione C, Venturelli E, Manzari A, Cavalleri A, Martinetti A, Secreto G.

J Steroid Biochem Mol Biol. 1995 Jun;52(6):541-6.

PMID:
7779758
43.

Abnormal production of androgens in women with breast cancer.

Secreto G, Zumoff B.

Anticancer Res. 1994 Sep-Oct;14(5B):2113-7. Review.

PMID:
7840509
44.

Testosterone levels as a marker of prognosis to goserelin treatment in metastatic breast cancer.

Secreto G, Boracchi P, Buzzoni R, Venturelli E, Cavalleri A, Dolci S.

Eur J Cancer. 1994;30A(11):1629-31.

PMID:
7833135
45.

Urinary testosterone as a marker of risk of recurrence in operable breast cancer.

Ballerini P, Oriana S, Duca P, Martinetti A, Venturelli E, Ferrari L, Dolci S, Secreto G.

Breast Cancer Res Treat. 1993;26(1):1-6.

PMID:
8400317
46.

Prenatal influences and breast cancer.

Stoll BA, Secreto G.

Lancet. 1992 Dec 12;340(8833):1478. No abstract available.

PMID:
1360603
47.

Urinary testosterone measurement by gas chromatography after solid-phase extraction and high-performance liquid chromatography.

Venturelli E, Manzari A, Cavalleri A, Benzo M, Secreto G, Marubini E.

J Chromatogr. 1992 Nov 6;582(1-2):7-12.

PMID:
1491060
48.

Cationic content in multiple mammary cysts.

Ballerini P, Callegari L, Del Prato I, Moglia D, Cerrotta A, Adorni L, Ferrari L, Secreto G.

Tumori. 1992 Jun 30;78(3):198-9.

PMID:
1440944
49.

New hormone-related markers of high risk to breast cancer.

Stoll BA, Secreto G.

Ann Oncol. 1992 Jun;3(6):435-8. Review.

PMID:
1498060
50.

Serum and urinary androgens and risk of breast cancer in postmenopausal women.

Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietro S.

Cancer Res. 1991 May 15;51(10):2572-6.

Supplemental Content

Loading ...
Support Center